Filing Flows › BioScience Health Innovations (BHIC) › Gross margin
BioScience Health Innovations (BHIC) gross margin by quarter
BioScience Health Innovations' gross margin was 61.1% in Q2 2025 (second quarter 2025), -11.9 pts from Q1 2025. Over the last 3 quarters it ranged from 55.6% (Q4 2024) to 73.0% (Q1 2025).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2025 | 61.1% | -11.9 pts | — |
| Q1 2025 | 73.0% | +17.5 pts | — |
| Q4 2024 | 55.6% | — | — |
Q2 2025 at a glance
BioScience Health Innovations, Q2 2025: revenue $1.8M (+358% year over year), operating margin 26.0%, net earnings $458K, operating cash flow $285K. The chart follows the revenue to costs, profit and cash.
Questions
What is BioScience Health Innovations' gross margin?
BioScience Health Innovations' gross margin was 61.1% in Q2 2025 (second quarter 2025), -11.9 pts from Q1 2025.
How has BioScience Health Innovations' gross margin changed?
Over the last 3 quarters it ranged from 55.6% (Q4 2024) to 73.0% (Q1 2025).
Q2 2025 results → · How BioScience Health Innovations makes money →